A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer

P Iversen; TLJ Tammela; S Vaage; O Lukkarinen; P Lodding; T Bull-Njaa; J Viitanen; P Hoisaeter; P Lundmo; F Rasmussen; J-E Johansson; B-E Persson; K Caroll

A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer

P Iversen, TLJ Tammela, S Vaage, O Lukkarinen, P Lodding, T Bull-Njaa, J Viitanen, P Hoisaeter, P Lundmo, F Rasmussen, J-E Johansson, B-E Persson, K Caroll

Research output: Contribution to journal › Article › Scientific › peer-review

51 Citations (Scopus)

Original language	English
Pages (from-to)	204-211
Journal	European Urology
Volume	42
Publication status	Published - 2002
Publication type	A1 Journal article-refereed

Keywords

bicalutamide
disease progression
early prostate cancer
standard care

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Iversen, P., Tammela, TLJ., Vaage, S., Lukkarinen, O., Lodding, P., Bull-Njaa, T., Viitanen, J., Hoisaeter, P., Lundmo, P., Rasmussen, F., Johansson, J.-E., Persson, B.-E., & Caroll, K. (2002). A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer. European Urology, 42, 204-211.

@article{a4fb57dd9e7d4e07a6f2934d95f4ca09,

title = "A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer",

keywords = "bicalutamide, disease progression, early prostate cancer, standard care, bicalutamide, disease progression, early prostate cancer, standard care",

author = "P Iversen and TLJ Tammela and S Vaage and O Lukkarinen and P Lodding and T Bull-Njaa and J Viitanen and P Hoisaeter and P Lundmo and F Rasmussen and J-E Johansson and B-E Persson and K Caroll",

year = "2002",

language = "English",

volume = "42",

pages = "204--211",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

}

Iversen, P, Tammela, TLJ, Vaage, S, Lukkarinen, O, Lodding, P, Bull-Njaa, T, Viitanen, J, Hoisaeter, P, Lundmo, P, Rasmussen, F, Johansson, J-E, Persson, B-E & Caroll, K 2002, 'A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer', European Urology, vol. 42, pp. 204-211.

TY - JOUR

T1 - A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer

AU - Iversen, P

AU - Tammela, TLJ

AU - Vaage, S

AU - Lukkarinen, O

AU - Lodding, P

AU - Bull-Njaa, T

AU - Viitanen, J

AU - Hoisaeter, P

AU - Lundmo, P

AU - Rasmussen, F

AU - Johansson, J-E

AU - Persson, B-E

AU - Caroll, K

PY - 2002

Y1 - 2002

KW - bicalutamide

KW - disease progression

KW - early prostate cancer

KW - standard care

KW - bicalutamide

KW - disease progression

KW - early prostate cancer

KW - standard care

M3 - Article

SN - 0302-2838

VL - 42

SP - 204

EP - 211

JO - European Urology

JF - European Urology

ER -